Hemodynamic Changes after Protamine Administration
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 102 (2), 308-314
- https://doi.org/10.1097/00000542-200502000-00011
Abstract
Background Protamine sulfate is standard therapy to reverse heparin anticoagulation. Hemodynamic responses to protamine are common, ranging from minor perturbations to cardiovascular collapse. Although severe fatal reactions occur, the relation of less extreme responses with postoperative mortality is unknown. Therefore, the authors tested the hypothesis that hemodynamic "protamine reactions" (systemic hypotension and pulmonary hypertension) are associated with mortality after cardiac surgery. Methods In a university hospital setting, the authors studied 6,921 coronary bypass patients using automated anesthesia record-keeping data and quality assurance databases. Degree/duration integrals of systemic hypotension (< 100 mmHg) and pulmonary hypertension (> 30 mmHg) for the 30-min after protamine administration were assessed for linear associations with mortality using multiple logistic regression models adjusting for risk factors. Results Overall mortality was 2%; greater hemodynamic responses were associated with increased mortality by odds ratios of 1.28 (systemic hypotension: 95% confidence interval, 1.14-1.43; P < 0.001) and 1.27 (pulmonary hypertension: 95% confidence interval, 1.06-1.48; P < 0.001) per 150-mmHg . min increment. Proximity of the response to protamine administration strengthened the relation, which persisted after exclusion of major hemodynamic disturbances. Tests for linearity confirmed an association even at the lowest range of values for both pressure effects. Conclusions Hemodynamic perturbations after protamine administration are independently related to in-hospital mortality after primary coronary artery bypass surgery; the relation is present even in the lowest observed range of values for both systemic hypotension and pulmonary hypertension. Although randomized trials are necessary to address causality, this evidence suggests that strategies that avoid or attenuate these reactions may improve patient care.Keywords
This publication has 15 references indexed in Scilit:
- A Dose-Determining Trial of Heparinase-I (Neutralase™) for Heparin Neutralization in Coronary Artery SurgeryAnesthesia & Analgesia, 2001
- Intraoperative physiologic variables and outcome in cardiac surgery: part I. In-hospital mortalityThe Annals of Thoracic Surgery, 2000
- Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypassJournal of the American College of Cardiology, 1998
- Complement activation by heparin-protamine complexes during cardiopulmonary bypass: Effect of C4A null alleleThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Effect of Methylprednisolone on Complement Activation During Heparin NeutralizationJournal of Cardiovascular Pharmacology, 1997
- Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.Journal of Clinical Investigation, 1995
- A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgeryJournal of Allergy and Clinical Immunology, 1990
- Association of Protamine IgE and IgG Antibodies with Life-Threatening Reactions to Intravenous ProtamineNew England Journal of Medicine, 1989
- C5a and Thromboxane Generation Associated with Pulmonary Vaso- and Broncho-constriction during Protamine Reversal of HeparinAnesthesiology, 1987